ALK gene rearrangements, ALK inhibitors, and the Lung Cancer Revolution, by Dr. D. Ross Camidge (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. D. Ross Camidge, medical oncologist at the University of Colorado, provides an overview of the newly identified ALK gene rearrangements, novel therapy to target this, and the promise of molecular on...